These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25085666)
1. Merkel cell carcinoma: current status of targeted and future potential for immunotherapies. Aldabagh B; Joo J; Yu SS Semin Cutan Med Surg; 2014 Jun; 33(2):76-82. PubMed ID: 25085666 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Becker JC; Stang A; Hausen AZ; Fischer N; DeCaprio JA; Tothill RW; Lyngaa R; Hansen UK; Ritter C; Nghiem P; Bichakjian CK; Ugurel S; Schrama D Cancer Immunol Immunother; 2018 Mar; 67(3):341-351. PubMed ID: 29188306 [TBL] [Abstract][Full Text] [Related]
4. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide. Paulson KG; Bhatia S J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528 [TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: Do you know your guidelines? Miles BA; Goldenberg D; Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756 [TBL] [Abstract][Full Text] [Related]
6. Large nuclear size correlated with better overall survival, Merkel cell polyomavirus positivity, and terminal deoxynucleotidyl transferase expression in Merkel cell carcinoma. Moran JMT; Biecek P; Donizy P; Wu CL; Kopczynski J; Pieniazek M; Ryś J; Hoang MP J Am Acad Dermatol; 2021 Feb; 84(2):550-552. PubMed ID: 33317843 [No Abstract] [Full Text] [Related]
7. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas. Vandeven N; Nghiem P Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685 [TBL] [Abstract][Full Text] [Related]
8. Why Merkel Cell Cancer Is Garnering More Attention. Voelker R JAMA; 2018 Jul; 320(1):18-20. PubMed ID: 29898204 [No Abstract] [Full Text] [Related]
10. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Paulson KG; Voillet V; McAfee MS; Hunter DS; Wagener FD; Perdicchio M; Valente WJ; Koelle SJ; Church CD; Vandeven N; Thomas H; Colunga AG; Iyer JG; Yee C; Kulikauskas R; Koelle DM; Pierce RH; Bielas JH; Greenberg PD; Bhatia S; Gottardo R; Nghiem P; Chapuis AG Nat Commun; 2018 Sep; 9(1):3868. PubMed ID: 30250229 [TBL] [Abstract][Full Text] [Related]
11. Update on the biology and clinical management of Merkel cell carcinoma. Thakuria M; LeBoeuf NR; Rabinowits G Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131 [TBL] [Abstract][Full Text] [Related]
13. [Merkel cell neoplasm unveiled]. Narusawa H Gan To Kagaku Ryoho; 2010 Apr; 37(4):634-7. PubMed ID: 20461892 [No Abstract] [Full Text] [Related]
14. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites. Ly TY; Walsh NM; Pasternak S Hum Pathol; 2012 Apr; 43(4):557-66. PubMed ID: 21940035 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma. Donepudi S; DeConti RC; Samlowski WE Semin Oncol; 2012 Apr; 39(2):163-72. PubMed ID: 22484188 [TBL] [Abstract][Full Text] [Related]
16. Molecular and immune targets for Merkel cell carcinoma therapy and prevention. Cohen L; Tsai KY Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890 [TBL] [Abstract][Full Text] [Related]